Translating Field Insights into Actionable Evidence to Better Inform Clinical Development & Improve Patient Outcomes

• Identify which questions truly reveal scientific gaps, build awareness and support adoption versus less actionable information
• Which HCPs to engage, how do best identify these individuals
• Learn which interactions are changing minds discover how collected insights can shape protocols, trial design and patient-centric approaches

Speakers:

Desmond Murphy

National Director - Rare Disease Medical Affairs Lead & MSL

Alnylam Pharmaceuticals